CLSI H56-A: Body Fluid Analysis for Cellular Composition

Under a microscope, cells suspended in cerebrospinal, pleural, peritoneal, bronchoalveolar, or synovial fluid can provide important clues about what is happening inside the body. For clinicians and laboratory professionals, turning those microscopic clues into reliable information begins with how that specimen is collected, transported, processed, and analyzed. CLSI H56-A, Body Fluid Analysis for Cellular Composition; Approved Guideline provides standardized laboratory procedures for collecting, processing, examining, storing, and reporting non-blood body fluids.

Purpose of Body Fluid Testing

Body fluid analysis for cellular composition is a laboratory medical procedure that identifies and evaluates cells (such as white and red blood cells) present in non-blood body fluids. It can provide important information to help doctors diagnose infections, inflammation, and malignancies in specific body cavities.

For clinical laboratories, accurately collecting, processing, examining, and reporting these specimens is essential for producing reliable laboratory results. Following established medical guidelines like CLSI H56-A helps assure safe collection, handling, and accurate reporting of body fluid cellular analysis.

What Is CLSI H56-A?

CLSI H56-A provides guidance for the collection, processing, examination, storage, and reporting of body fluid specimens to help characterize inflammatory, infectious, neoplastic, and immune-related changes. It covers both manual and automated methods for counting cellular components and identifying normal and abnormal elements, while also addressing preanalytical, analytical, and postanalytical factors that can affect body fluid cellular analysis.

The guideline also discusses additional testing that may be performed on body fluid specimens in the routine clinical laboratory.

Which Body Fluids Are Covered?

Body fluids can vary significantly in their cellular composition and clinical significance. CLSI H56-A addresses several types of specimens encountered in the clinical laboratory, including:

Cerebrospinal Fluid (CSF)

CSF surrounds the brain and spinal cord and can be examined for changes in cellular composition that may indicate infection, inflammation, bleeding, or other abnormalities affecting the central nervous system.

Serous Fluids (Pleural, Peritoneal, and Pericardial)

Serous fluids are found within body cavities surrounding major organs. Pleural fluid surrounds the lungs and chest, pericardial fluid surrounds the heart, and peritoneal fluid is found within the abdominal cavity. Changes in the amount or cellular composition of these fluids can occur with conditions such as inflammation, infection, trauma, and malignancy.

Related Fluids (Peritoneal Dialysate and Peritoneal Lavage)

Peritoneal dialysate acts as a substitute kidney for people with end-stage kidney failure, while peritoneal lavage is a medical procedure that involves putting sterile fluid into the belly area (peritoneal cavity) and then taking it out. Cellular analysis of these specimens can help provide information about inflammatory or infectious processes.

Bronchoalveolar Lavage (BAL) Fluid

BAL fluid is collected from the lower respiratory tract during a bronchoscopy procedure. Examining its cellular composition can provide information about inflammatory and infectious processes affecting the lungs.

Synovial Fluid

Synovial fluid is found within joint cavities, where it helps lubricate and protect joints. Changes in its cellular composition can provide clues about joint inflammation, infection, or other disorders.

By addressing multiple specimen types within one guideline, CLSI H56-A provides laboratories with a framework for approaching cellular analysis consistently across different body fluid specimens.

Who Should Use CLSI H56-A?

CLSI H56-A is intended for medical technologists, pathologists, microbiologists, cytologists, nurses, and other healthcare professionals responsible for the collection and transport of body fluid specimens to the clinical laboratory, as well as the processing, testing, and reporting of results. The standard is also intended for manufacturers of products or instruments used for body fluid testing.

CLSI H56-A and FDA Recognition

CLSI H56-A has been recognized by the U.S. Food and Drug Administration (FDA) as a consensus standard. The FDA’s database lists CLSI H56-A under in vitro diagnostics and indicates complete recognition of the standard. The recognition applies to certain automated cell and differential cell counter devices.